Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 2, 2024 8-K
3 Sep 10, 2024 3
8-K Sep 3, 2024 8-K
4 Aug 14, 2024 4
4 Aug 14, 2024 4
144 Aug 12, 2024
144 Aug 12, 2024
8-K Aug 8, 2024 CURRENT REPORT
424B5 Aug 1, 2024 424B5
8-K Aug 1, 2024 8-K
10-Q Aug 1, 2024 10-Q
8-K Jun 20, 2024 CURRENT REPORT
8-K Jun 13, 2024 CURRENT REPORT
8-K Jun 7, 2024 8-K
4 Jun 6, 2024 4
4 Jun 6, 2024 4
4 Jun 6, 2024 4
4 Jun 6, 2024 4
4 Jun 6, 2024 4
4 Jun 6, 2024 4
10-Q May 2, 2024 10-Q
8-K Apr 25, 2024 CURRENT REPORT
EFFECT Apr 24, 2024
CORRESP Apr 22, 2024
ARS Apr 22, 2024 ARS
← Newer Page 4 of 26 · 646 filings Older →